infohep is no longer being updated. Visit www.aidsmap.com for HIV and hepatitis news.

Glossary

Please select an letter from the A-Z list or search

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
early virological response (EVR)

A reduction in hepatitis C RNA viral load by week 12 of treatment. A partial early virological response (pEVR) means that it has dropped by at least 2 log10 (99%). A complete early virological response (cEVR) means that viral load is undetectable by week 12.

effectiveness

How well something works (in real life conditions). See also ‘efficacy’.

efficacy

How well something works (in a research study). See also ‘effectiveness’.

encephalopathy

A disease or infection affecting the brain.

end of treatment response (ETR, EOT)

An undetectable hepatitis C RNA viral load when treatment is ended. This does not necessarily mean that hepatitis C is cured – see ‘sustained virological response’.

endogenous

Coming from within.

endoscopy

Viewing the inside of the body cavity with a flexible instrument using fibre optics.

endpoint

In a clinical trial, a clearly defined outcome which is used to evaluate whether a treatment is working or not. Trials usually have a single primary endpoint (e.g. having an undetectable viral load) as well as a few secondary endpoints, covering other aspects of treatment safety, tolerability and efficacy.

end-stage liver disease (ESLD)

When the liver loses most or all of its functions, leading to liver failure.

enteric

Associated with the gut.

epidemiology

The study of the causes of a disease, its distribution within a population, and measures for control and prevention. Epidemiology focuses on groups rather than individuals.

epidermis

The outer layers of the skin.

epilepsy

A condition where someone has a tendency to have recurrent seizures (fits).

epitope

The part of an antigen which the immune system recognises.

Epstein-Barr virus

The virus that causes oral hairy leukoplakia and glandular fever. Sometimes called mononucleosis.

equivalence trial

A clinical trial which aims to demonstrate that a new treatment is no better or worse than an existing treatment. While the two drugs may have similar results in terms of virological response, the new drug may have fewer side-effects, be cheaper or have other advantages. See also ‘non-inferiority trial’ and ‘superiority trial’.

erectile dysfunction

A man's inability to have or maintain an erection, also known as ED or impotence.

erythema

A red skin eruption or rash.

erythropoietin

A natural hormone made in the kidneys to stimulate the production of red blood cells by the bone marrow.

ethics committee

A panel of people which reviews any proposed clinical trial to ensure that the participants are protected from any foreseeable exploitation or harm. In the US known as the Institutional Review Board.

exclusion criteria

Reasons that would disqualify a person from joining a trial.

exogenous

Coming from outside the body.

expanded access scheme

A programme that allows access to an experimental drug outside clinical trials for people in particular need.

experimental study

A study design in which researchers provide treatment in a pre-planned, experimental way and record the outcome. Clinical trials, such as randomised controlled trials, are experimental studies.

extended rapid virological response (eRVR)

An undetectable hepatitis C RNA viral load within 4 weeks of starting treatment, maintained until at least week 12.

extrahepatic

Something that has an effect outside the liver, for example when viral hepatitis affects the kidneys or causes depression.